U.S. Biotech Stock News

Cintas Corporation’s recent past appearances in investor letters and on Jim Cramer’s show have spotlighted its role as a small-business barometer, as fund managers reassessed the company amid concerns about employment trends, pricing, and cost pressures despite better-than-expected quarterly results. These differing views underscore a tension between Cintas’ history of expanding services and free cash flow strength, and fresh worries that a softer employment backdrop and margin pressures...

Key Insights The considerable ownership by individual investors in TXO Partners indicates that they collectively have a...

Bunge Global SA ( NYSE:BG ) will pay a dividend of $0.70 on the 3rd of March. The payment will take the dividend yield...

If you are wondering whether Wells Fargo is still a value play after such a big run up, or if you might be arriving late to the party, this breakdown is for you. The stock has climbed 3.7% over the last week, 8.4% over the past month, and is now up 31.3% year to date and 33.0% over the last 12 months. That caps a multi year rebound of 143.3% over 3 years and 257.2% over 5 years. That surge has come as investors have steadily warmed back up to big US banks, with sentiment improving around...

Immunome (IMNM) grabbed investor attention after revealing that its pivotal Phase 3 RINGSIDE trial for desmoid tumors hit both its primary and key secondary endpoints, setting up a potential US approval filing in 2026. See our latest analysis for Immunome. The upbeat RINGSIDE data has been the clear catalyst behind Immunome’s recent rally, with a 30 day share price return of 36.99 percent and a 90 day share price return of 161.18 percent helping drive a 3 year total shareholder return of...

Insiders who acquired US$146.1k worth of Humacyte, Inc.'s ( NASDAQ:HUMA ) stock at an average price of US$1.38 in the...

If you are wondering whether Eaton is still worth buying after its big run over the last few years, you are not alone. This article is going to dig into what the current share price really implies. Despite long term gains of 120.9% over 3 years and 207.9% over 5 years, the stock has cooled recently, slipping 3.5% over the last week and 6.4% over the last month, and leaving year to date returns slightly negative at 0.6% and about 3.7% lower than a year ago. Those moves come against a backdrop...

Wondering if Healthpeak Properties is starting to look like a bargain after a tough run, or if the market sees trouble that is not obvious yet? Let us walk through what the numbers are really saying about its value. The stock is trading around $16.36, with returns of about -0.8% over the last week, -5.7% over the last month, and a much steeper -18.8% year to date, which has clearly tested investors' patience. Recently, the stock has been in focus as investors reassess listed healthcare REITs...

The recent 14% drop in Future FinTech Group Inc.'s ( NASDAQ:FTFT ) stock could come as a blow to insiders who purchased...

In December 2025, Intuitive Surgical received U.S. FDA clearance to use its da Vinci Single Port robotic system for inguinal hernia repair, cholecystectomy, and appendectomy, extending earlier approvals in urology, colorectal, thoracic, and transoral surgery. This expansion into high-volume general surgery, backed by extensive clinical evidence and existing approvals across the U.S., Europe, Japan, and Korea, could meaningfully deepen utilization of Intuitive’s SP platform. We’ll now examine...

Anyone interested in Capri Holdings Limited ( NYSE:CPRI ) should probably be aware that the Interim Chief Financial...

Wondering if Coca-Cola at around $70 is still a refreshing buy or if most of the upside has already been poured into the price? You are not alone in asking whether KO is good value right now. The stock is up 13.8% year to date and 14.3% over the last year, even after a modest 1.1% pullback over the past month. This suggests that the market still sees KO as a relatively steady compounder rather than a high risk swing trade. Recently, investors have been digesting news around Coca-Cola's...

You may think that with a price-to-sales (or "P/S") ratio of 7.3x C4 Therapeutics, Inc. ( NASDAQ:CCCC ) is a stock...

Valero Energy (VLO) has quietly given back some gains over the past month, even though its longer term track record and solid profitability trends still stand out compared with many refining peers. See our latest analysis for Valero Energy. That recent pullback, including a 1 month share price return of minus 10.42 percent and a 7 day share price return of minus 7.13 percent to about 162.82 dollars, comes after a strong run, with a year to date share price return above 30 percent and a 5 year...

Dell Technologies recently declared a quarterly cash dividend of US$0.525 per share, payable on January 30, 2026 to shareholders of record on January 20, 2026, following an 18% increase to its annual dividend earlier this year. At the same time, Dell is sharpening its focus on hybrid AI infrastructure, governance, and sovereign AI while contending with sector-wide sentiment shifts and insider selling that have influenced investor confidence. Next, we’ll examine how Dell’s AI-focused...

Wondering if Delta Air Lines is still good value after its latest run up, or if the easy money has already been made? This breakdown walks through what the numbers are really saying about the stock. Delta shares have climbed 5.5% over the last week, 21.8% over the past month, and are now up 20.4% year to date, building on gains of 18.4% over 1 year and 122.3% over 3 years. Recently, investors have been reacting to stronger travel demand, improving capacity on key international routes, and...

Stride (LRN) has been quietly grinding higher, with the stock up about 3% in the past day and 6% over the past week, even as longer term returns look much rougher. See our latest analysis for Stride. The recent pop takes the share price to $65.82, but that comes after a bruising 90 day share price return of around negative 52 percent and a one year total shareholder return near negative 39 percent, even though long term total shareholder returns remain strongly positive. If you are weighing...

Comstock Resources (CRK) just caught a downdraft, with the stock sliding as natural gas prices retreated on milder weather forecasts, heavy production, and swollen storage, which is pressuring sentiment across gas focused producers. See our latest analysis for Comstock Resources. The latest pullback leaves Comstock’s share price at about $21.28, with a 7 day share price return of minus 13.28 percent and 30 day return of minus 15.89 percent, but a still solid 90 day share price return of 24.08...

In recent months, HubSpot reported constant-currency revenue of US$810.00 million for Q3 2025, growing 18.4% year over year on the back of AI-driven product uptake, seat expansion, and more multi-hub deals, while keeping forward guidance unchanged aside from currency effects. At the same time, investor skepticism about the profitability of AI spending and worries about a potential AI bubble weighed on sentiment toward HubSpot, despite its continued operational momentum. We’ll now examine how...

A number of C&F Financial Corporation ( NASDAQ:CFFI ) insiders sold their shares in the last year, which may have...

Polestar Automotive Holding UK (NasdaqGM:PSNY) just followed its 1 for 30 reverse stock split with a fresh 600 million dollar subordinated loan from a Geely affiliate, a one two punch aimed squarely at liquidity and listing risk. See our latest analysis for Polestar Automotive Holding UK. Even with the reverse split and fresh Geely backed funding, momentum has been sharply negative. The latest 12.74 share price sits against a roughly 61 percent year to date share price return and a three year...

GrowGeneration Corp. ( NASDAQ:GRWG ) shareholders have had their patience rewarded with a 30% share price jump in the...

In recent days, Southern’s settlement in Georgia’s All-Source Request for Proposals was outlined as adding about US$4.00 billion to its capital expenditure plans, alongside ongoing construction of new natural gas generation units at Plant Yates to help meet rising state power demand. This combination of higher planned spending and investment in flexible, potentially hydrogen-capable turbines at Plant Yates underscores how Southern is committing more capital to support long-term grid...

The Morning Bull - US Market Morning Update Wednesday, Dec, 17 2025 US stock futures are edging higher this morning, with contracts linked to the S&P 500 up around 0.1 percent as investors weigh softer economic signals at home against easing inflation abroad. Fresh US business surveys show manufacturing at its weakest in five months and a New York activity index deeply negative at minus 20, a sign that factory demand is fading and pricing power is cooling. At the same time, UK inflation has...